<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rajkumar</surname>
    <given-names>S Vincent</given-names>
   </name>
   <name>
    <surname>Jacobus</surname>
    <given-names>Susanna</given-names>
   </name>
   <name>
    <surname>Callander</surname>
    <given-names>Natalie S</given-names>
   </name>
   <name>
    <surname>Fonseca</surname>
    <given-names>Rafael</given-names>
   </name>
   <name>
    <surname>Vesole</surname>
    <given-names>David H</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>Michael E</given-names>
   </name>
   <name>
    <surname>Abonour</surname>
    <given-names>Rafat</given-names>
   </name>
   <name>
    <surname>Siegel</surname>
    <given-names>David S</given-names>
   </name>
   <name>
    <surname>Katz</surname>
    <given-names>Michael</given-names>
   </name>
   <name>
    <surname>Greipp</surname>
    <given-names>Philip R</given-names>
   </name>
  </person-group>
  <article-title>Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial</article-title>
  <source>The Lancet Oncology</source>
  <year>2010</year>
  <volume>11</volume>
  <issue>1</issue>
  <fpage>29</fpage>
  <lpage>37</lpage>
  <pub-id pub-id-type="doi">10.1016/S1470-2045(09)70284-0</pub-id>
  <pub-id pub-id-type="pmid">19853510</pub-id>
 </element-citation>
</ref>
